|
Drug Uses
Vaniqa (Cream) is a prescription medication applied to the
skin for the reduction of unwanted facial hair in women. Vaniqa
interferes with an enzyme found in the hair follicle of the
skin needed for hair growth. This results in slower hair growth
and improved appearance where Vaniqa is applied. Vaniqa does
not permanently remove hair or "cure" unwanted facial
hair. It is not a depilatory. Your treatment program should
include continuation of any hair removal technique you are
currently using. Vaniqa will help you manage your condition
and improve your appearance.
Apply a thin layer of Vaniqa Cream to affected
areas of the face and adjacent involved areas under the chin
and rub in thoroughly. Do not wash treated area for at least
4 hours. Use twice daily at least 8 hours apart or as directed
by a physician. You should continue to use hair removal techniques
as needed in conjunction with Vaniqa. (Vaniqa should be applied
at least 5 minutes after hair removal). Cosmetics or sunscreens
may be applied over treated areas after cream has dried.
Do not use Vaniqa if you have had an allergic
reaction to it in the past. Vaniqa is in the FDA pregnancy
category C. This means that it is not known whether Vaniqa
will harm an unborn baby. Do not use this medication without
first talking to your doctor if you are pregnant. It is also
not known whether Vaniqa passes into breast milk. Do not use
Vaniqa without first talking to your doctor if you are breast-feeding
a baby. Vaniqa has not been approved for use by children younger
than 12 years of age.
If you forget or miss a dose of Vaniqa
do not try to "make it up". Return to your normal
application schedule as soon as you can.
Vaniqa may cause temporary redness, stinging,
burning, tingling or rash on areas of the skin where it is
applied. Hair bumps may also occur. If these persist, consult
your doctor. Treatment related skin adverse events that occurred
in less than 1% of the subjects treated with Vaniqa are: bleeding
skin, cheilitis, and contact dermatitis, swelling of lips,
herpes simplex, numbness and rosacea. Adverse events were
primarily mild in intensity and generally resolved without
medical treatment or discontinuation of Vaniqa.
Store at 25? C (77? F); excursions permitted
to 15? C-30? C (59? F-86? F). Do not freeze. See tube crimp
and carton end for expiration date and lot number.
An overdose of Vaniqa is not likely to
occur. If the cream has been ingested, or if you suspect an
overdose has occurred, contact your doctor, hospital emergency
room, or poison control left for advice.
Avoid getting this medication in your eyes,
nose, or mouth. If this occurs, wash the area with water.
If Vaniqa gets in your eyes, rinse thoroughly with water and
contact your doctor.
| Description |
Price |
Order Now |
|
|
|
|
|
|
|
|
|
